Enliven Therapeutics Logo (full size)
Enliven Therapeutics Logo icon/symbol
Enliven Therapeutics Logo (full size) on a dark background
Enliven Therapeutics Logo icon/symbol on a dark background
About Enliven Therapeutics
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company's lead product candidates comprise ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial in adults with solid tumors with HER2 alterations. The company is headquartered in Boulder, Colorado.
July 6th, 2024
